AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Simmons, ML Armstrong, P Califf, R Barnathan, E Hoynck, M Scherer, J Wallentin, L
Citation: Ml. Simmons et al., Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial, LANCET, 357(9272), 2001, pp. 1915-1924

Authors: Szczech, LA Reddan, DN Owen, WF Califf, R Racz, M Jones, RH Hannan, EL
Citation: La. Szczech et al., Differential survival after coronary revascularization procedures among patients with renal insufficiency, KIDNEY INT, 60(1), 2001, pp. 292-299

Authors: Cho, L Topol, EJ Balog, C Foody, JM Booth, JE Cabot, C Kleiman, NS Tcheng, JE Califf, R Lincoff, MA
Citation: L. Cho et al., Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender - Pooled analysis from EPIC, EPILOG and EPISTENT trials, J AM COL C, 36(2), 2000, pp. 381-386

Authors: Topol, CE Califf, RM Simes, RJ Van de Werf, F Diaz, R Paolasso, E Aylward, PE Keech, A Klein, W Piegas, L Tomov, I Armstrong, PW Widimsky, P Grande, P Halinen, M Vahanian, A Neuhaus, K Dimas, AP Preda, I Kristinsson, A Tzivoni, D Ardissino, D White, HD Madsen, S Sugrue, D Sadowski, Z Seabra-Gomes, R Apetrei, E Dalby, A Betriu, A Pfisterer, M Verheugt, F Fox, K Bates, ER Gibler, WB Granger, CB Harrington, RA Hochman, JS Holmes, DR Kleiman, NS Lee, KL Moliterno, DJ Newby, LK Ohman, EM Califf, R Newby, K Zillman, L Lee, K Lemons, P McCourt, B Campbell, C Tardiff, B Snapp, J Bassett, K Hodgson, P Hannan, K Kandzari, L Hawkins, S Hinman-Smith, E McDougal, M Raffetto, K Thompson, D Wehrle, T Ange, C Brown, R Grissom, G Heuckel, M McCall, J Pennachi, W Spychala, M Veasey, S Pullium, M Journey, T Quintero, K Mark, D Davidson-Ray, L Diner, L Nelson, C Sowers, C Webb, G Young, M Bhapkar, M Pacchiana, C Sparapani, R Tuttle, R Weaver, D Borzak, S Douthat, L Topol, E Moliterno, D Konczos, L Baishnab, R Baishnab, R Bakos, A Blashford, L Bratsch, J Brown, K Cadorini, E Carlson, J Clemmons, P DelValle, M Drabik, M Fu, G Gates, K Gibson, Y Heil, L Hill, N Klancar, R McHale, B Montague, E Pasca, N Pergi, L Randall, R Rosso, R Sankovich, K Smith, D Wisniewski, L Witkowski, M Zovkic, V Alexander, K Bhatt, D Brener, S Campbell, L Cho, L Cole, C Deedy, M Foody, J Gassler, J Ghaffari, S Haas, G Kapadia, S Lauer, M Lauer, MS Lincoff, M Lutton, S Marso, S Mukherjee, D Patel, V Penn, M Robbins, M Roe, M Sila, C Thamilarasan, M Wagner, G Armstrong, P Bestilny, S Van de Werf, F Budts, W Graux, S Luyten, A Simes, J Keech, A Kava, M Bower, T Chan, S Crampton, L Monro, C Nayak, M Parente, G Riley, V Wilton, D Aylward, P Dolan, S Thomas, C White, H Scott, M Frye, R Alpert, J Bertrand, M Ryan, T Fisher, L Asarch, L Smith, M Lim, L Bokslag, M Chiu, P Chung, J Collins, S Dougherty, C Guimaraes, D Hakim, Z Mathieson, J Montgomery, L Novotny, B Steiner, B Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345

Authors: Phillips, RS Hamel, MB Teno, JM Soukup, J Lynn, J Califf, R Vidaillet, H Davis, RB Bellamy, P Goldman, L
Citation: Rs. Phillips et al., Patient race and decisions to withhold or withdraw life-sustaining treatments for seriously ill hospitalized adults, AM J MED, 108(1), 2000, pp. 14-19

Authors: Pfeffer, MA McMurray, J Leizorovicz, A Maggioni, AP Rouleau, JL Van de Werf, F Henis, M Neuhart, E Gallo, P Edwards, S Sellers, MA Velazquez, E Califf, R
Citation: Ma. Pfeffer et al., Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design, AM HEART J, 140(5), 2000, pp. 727-734

Authors: Topol, EJ Easton, JD Amarenco, P Califf, R Harrington, R Graffagnino, C Davis, S Diener, HC Ferguson, J Fitzgerald, D Shuaib, A Koudstaal, PJ Theroux, P Van de Werf, F Willerson, JT Chan, R Samuels, R Ilson, B Granett, J
Citation: Ej. Topol et al., Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial, AM HEART J, 139(6), 2000, pp. 927-933

Authors: Califf, R Shah, M
Citation: R. Califf et M. Shah, Proceedings of a symposium - How should phase II trials in cardiovascular medicine be conducted? Hilton Head, South Carolina - October 3-4, 1997 - Introduction, AM HEART J, 139(4), 2000, pp. S131-S132

Authors: Wenger, NS Phillips, RS Teno, JM Oye, RK Dawson, NV Liu, HH Califf, R Layde, P Hakim, R Lynn, J
Citation: Ns. Wenger et al., Physician understanding of patient resuscitation preferences: Insights andclinical implications, J AM GER SO, 48(5), 2000, pp. S44-S51

Authors: Puchalski, CM Zhong, ZS Jacobs, MM Fox, E Lynn, J Harrold, J Galanos, A Phillips, RS Califf, R Teno, JM
Citation: Cm. Puchalski et al., Patients who want their family and physician to make resuscitation decisions for them: Observations from SUPPORT and HELP, J AM GER SO, 48(5), 2000, pp. S84-S90

Authors: Van de Werf, F Adgey, J Ardissino, D Armstrong, PW Aylward, P Barbash, G Betriu, A Binbrek, AS Califf, R Diaz, R Fanebust, R Fox, K Granger, C Heikkila, J Husted, S Jansky, P Langer, A Lupi, E Maseri, A Meyer, J Mlczoch, J Mocceti, D Myburgh, D Oto, A Paolasso, E Pehrsson, K Seabra-Gomes, R Soares-Piegas, L Sugrue, D Tendera, M Topol, E Toutouzas, P Vahanian, A Verheugt, F Wallentin, L White, H Berioli, S Bluhmki, E Brower, R Danays, T Fox, NL Girault, C Goetz, G Houbracken, K Jakob, H Kaye, J Sarelin, H Clow, FW Hacke, W von Kummer, L Lesaffre, E Bluhmki, E Bogaerts, K Munster, K Scheys, I Truyen, M Clow, FW Fox, KAA Brower, R Hallstrom, A Jones, D Maggioni, A Weaver, D
Citation: F. Van De Werf et al., Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, LANCET, 354(9180), 1999, pp. 716-722
Risultati: 1-11 |